Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 43, 2017 - Issue 2
Submit an article Journal homepage
256
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part I: purification of decayed thorium-227 on cation exchange columns

Janne Olsen FrenvikTechnology Development, Bayer AS, Lysaker, Oslo, Norway; Correspondence[email protected], [email protected]
,
Knut DyrstadKD Metrix, Oslo, Norway;
,
Solveig KristensenSchool of Pharmacy, University of Oslo, Blindern, Norway;
&
Olav B. RyanThorium Conjugate Research, Bayer AS, Lysaker, Oslo, Norway
Pages 225-233 | Received 09 Mar 2016, Accepted 06 Sep 2016, Published online: 26 Sep 2016

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Janne Olsen Frenvik, Knut Dyrstad, Solveig Kristensen & Olav B. Ryan. (2017) Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part II: purification of targeted thorium conjugates on cation exchange columns. Drug Development and Industrial Pharmacy 43:9, pages 1440-1449.
Read now

Articles from other publishers (3)

Thomas Bouvarel, Nadine Bremeyer, Mimi Gao, Wiebke Holkenjans, Terence Hetzel, Reinhard Pell, Valentina D’Atri & Davy Guillarme. (2023) Tackling Issues Observed during the Development of a Liquid Chromatography Method for Small Molecule Quantification in Antibody-Chelator Conjugate. Molecules 28:6, pages 2626.
Crossref
Romain Eychenne, Michel Chérel, Férid Haddad, François Guérard & Jean-François Gestin. (2021) Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”. Pharmaceutics 13:6, pages 906.
Crossref
Ján Kozempel, Olga Mokhodoeva & Martin Vlk. (2018) Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators. Molecules 23:3, pages 581.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.